The analysis follows the contrast agent through a sequence of repeated images, measuring how signal intensity changes over time after intravenous administration. Those signal-time patterns are converted into contrast-agent concentration, which can then be analyzed mathematically. The resulting measurements provide information about tissue perfusion and vascular permeability that is not available from static anatomical images alone.
Pharmacokinetic models provide the framework for translating contrast-agent concentration over time into quantitative parameters such as Ktrans, kep, and extracellular volume fraction. Because these values depend on the analysis model, consistent modeling is essential for reliable interpretation. Standardized modeling also makes measurements easier to compare across examinations and supports clinically meaningful assessment of tissue physiology.
Conventional MRI primarily depicts anatomical structure, whereas DCE-MRI quantification adds physiological information derived from contrast-agent behavior over time. This distinction allows imaging to examine characteristics such as tissue perfusion and vascular permeability rather than appearance alone. In medicine, the additional information can help characterize tumors and evaluate vascular changes associated with angiogenesis.
The examination begins with intravenous administration of a contrast agent, followed by repeated magnetic resonance images acquired as the agent produces changing signal intensity in the tissue. The resulting time series is processed to estimate contrast-agent concentration and fit pharmacokinetic models. Consistent timing, injection conditions, and image acquisition are important because each affects the quantitative measurements.
Quantitative results depend on how the contrast agent is administered and how rapidly images capture its passage through tissue. Variations in injection or acquisition can alter the measured signal-time pattern before modeling begins. Standardized procedures therefore improve reliability and clinical interpretability, helping ensure that differences in parameters reflect tissue physiology rather than inconsistent examination conditions.
Its applications include characterizing tumors, assessing angiogenesis, evaluating tissue blood flow, and monitoring response to therapy. The measurements can reveal physiological changes that may not be evident from anatomy alone, making them useful for studying tumor vascular behavior and treatment-associated changes. Reliable application depends on standardized acquisition, contrast administration, and pharmacokinetic analysis.